J9130 HCPCS code: Dacarbazine, 100 mg
J9130 is the HCPCS Level II code for dacarbazine, 100 mg. In 2024 Medicare paid an average of $2.93 per service for J9130 across 18,443 services. Its Medicare coverage code is D (Special coverage instructions apply): Medicare covers it when its national or local coverage criteria are met. The NCCI unit limit is 24 per day on outpatient hospital claims. Medicare volume fell 4% from 2022 to 2024 (19,166 to 18,443 services). In 2024, about 671 clinicians billed Medicare for J9130 for 384 beneficiaries; Florida, California, Texas accounted for 50% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1D — Chemotherapy |
| Added | 1986-01-01 |
| Last action effective | 2004-01-01 |
Who bills J9130 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 671 |
| Medicare beneficiaries | 384 |
| States with claims | 12 |
| Share of services in top 3 states (Florida, California, Texas) | 50% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J9130, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 19,166 | 416 | $4.23 | $3.37 |
| 2023 | 19,497 | 400 | $3.79 | $3.01 |
| 2024 | 18,443 | 384 | $3.71 | $2.93 |
States with the most J9130 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 2,509 | $2.96 |
| California | 1,743 | $2.90 |
| Texas | 1,730 | $2.90 |
| Illinois | 1,290 | $2.99 |
| New York | 1,061 | $2.99 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 24 | Clinical: Society Comment |
| practitioner claims | 24 | Clinical: Society Comment |
What changed for J9130
- 1986-01-01: J9130 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J9130?
J9130 is the HCPCS Level II code for dacarbazine, 100 mg. Short descriptor: "Dacarbazine 100 mg inj".
How much does Medicare pay for J9130?
In 2024, the average Medicare payment was $2.93 per service (average allowed $3.71).
Does Medicare cover J9130?
Coverage code D — Special coverage instructions apply. Medicare covers it when its national or local coverage criteria are met.
How many units of J9130 can be billed per day?
24 on outpatient hospital claims; 24 on practitioner claims (NCCI medically unlikely edits).
Related J91 codes
- J9100 — Injection, cytarabine, 100 mg
- J9118 — Injection, calaspargase pegol-mknl, 10 units
- J9119 — Injection, cemiplimab-rwlc, 1 mg
- J9120 — Injection, dactinomycin, 0.5 mg
- J9144 — Injection, daratumumab, 10 mg and hyaluronidase-fihj
- J9145 — Injection, daratumumab, 10 mg
- J9150 — Injection, daunorubicin, 10 mg
- J9151 — Injection, daunorubicin citrate, liposomal formulation, 10 mg
- J9153 — Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
- J9155 — Injection, degarelix, 1 mg
- J9160 — Injection, denileukin diftitox, 300 micrograms
- J9161 — Injection, denileukin diftitox-cxdl, 1 mcg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J9130
- Watch J9130 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J9130
Sources: CMS HCPCS Level II release October 2026; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.